VIRUS TODAY: Congress prepares to vote on relief package

Posted 12/21/20

Here's what's happening Monday with the coronavirus pandemic in the U.S.:

THREE THINGS TO KNOW TODAY

—Congress is preparing to vote on a delivering long-sought cash to businesses and …

You must be a member to read this story.

Join our family of readers for as little as $5 per month and support local, unbiased journalism.


Already have an account? Log in to continue. Otherwise, follow the link below to join.

Please log in to continue

Log in
I am anchor

VIRUS TODAY: Congress prepares to vote on relief package

Posted

Here's what's happening Monday with the coronavirus pandemic in the U.S.:

THREE THINGS TO KNOW TODAY

—Congress is preparing to vote on a delivering long-sought cash to businesses and individuals as well as resources to vaccinate a nation confronting a frightening surge in COVID-19 cases and deaths. The package would establish a temporary $300 per week supplemental jobless benefit and a $600 direct stimulus payment to most Americans.

—California’s overwhelmed hospitals are for coronavirus patients, and a handful of facilities in hard-hit Los Angeles County are drawing up emergency plans in case they have to limit how many people receive life-saving care.

—President-elect on live television as part of a growing effort to convince the American public the inoculations are safe. The president-elect took a dose of Pfizer's vaccine at a hospital not far from his Delaware home.

THE NUMBERS: The seven-day rolling average for daily new deaths in the U.S. increased over the pasts two weeks from 2,190 on Dec. 6 to 2,625 on Dec. 20, according to data from Johns Hopkins University.

DEATH TOLL: The U.S. death toll stands at 317,858 people, about 5,000 more than the population of Stockton, California.

QUOTABLE: “The prisoners feel so helpless because they can’t control it and they can’t stop it. They feel like they’re sitting ducks — and they are.” — Matt Tjapkes of Humanity for Prisoners, a nonprofit dedicated to inmates’ medical rights in Michigan. A survey conducted by The Marshall Project and The Associated Press found that that were imposed earlier this year to limit spread of the virus.

ICYMI: , hoping they can fill a key gap as vaccines remain months off for most people. One company tested more than 3,300 antibodies before choosing two for its drug, which has gone into the arm of a U.S. president and others fighting COVID-19.

ON THE HORIZON: A second vaccine, produced by Moderna, is It joins Pfizer’s in the nation’s arsenal against the COVID-19 pandemic.

___

Find AP’s full coverage of the coronavirus pandemic at

x